What challenges are associated with multi-regional trials?

Multi-regional trials face barriers such as regulatory differences, cultural disparities in patient recruitment, and logistics in managing diverse research sites. Addressing these challenges requires robust planning and collaboration with expert partners.

How do you select regions for multi-regional trials?

Choosing regions often depends on factors like the disease prevalence, patient demographics, regulatory requirements, and access to medical infrastructure. Engaging local experts is imperative for effective site selection.

Are multi-regional trials more expensive?

While multi-regional trials can incur higher upfront costs due to logistics and regulation, they often lead to faster regulatory approval and broader applicability of findings, making them cost-effective in the long run.